MU8-22948-65420
1 vaccination
4 coded responses
12 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 300 / GA
- Registered
- 2022-06-21
- Relationship
- Child or adolescent in my care
- Guardian
- KMU-27062-13354
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-21
Registered in v-safe
-
2022-06-21
Dose 1 — Moderna
- 2022-06-22
-
2022-06-23
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Fair · Irritability/cryingUnder 3 check-in
-
2022-06-24
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Fair · Irritability/cryingUnder 3 check-in
- 2022-06-25
- 2022-06-26
- 2022-06-28
- 2022-07-05
-
2022-07-12
Survey response — day 21, dose 1, under 3MedDRA: Pyrexia — Feeling: Fair · Be unable to work or attend schoolFree text: FeverMedDRA releases: 2024-11 · check-in free text available
-
2022-08-02
Survey response — day 42, dose 1, under 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend schoolFree text: CovidMedDRA releases: 2024-11 · check-in free text available
-
2022-09-20
Survey response — 3 months, dose 1, under 3MedDRA: Cough, Rhinorrhoea — Feeling: Fair · Be unable to work or attend schoolFree text: Runny nose and coughMedDRA releases: 2024-11 · check-in free text available
-
2022-12-20
Survey response — 6 months, dose 1, under 3MedDRA: Hand-foot-and-mouth disease, Respiratory syncytial virus infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Hand foot and mouth and RSVMedDRA releases: 2024-11 · check-in free text available
-
2022-12-20
Report sent to call center — 6 months, dose 1, under 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-12-21
- 2023-06-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-21 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 12 (Under 3) — day 21, dose 1, under 3
Symptoms: Fever
Release 12 (Under 3) — day 42, dose 1, under 3
Symptoms: Covid
Release 12 (Under 3) — 3 months, dose 1, under 3
Symptoms: Runny nose and cough
Release 12 (Under 3) — 6 months, dose 1, under 3
Symptoms: Hand foot and mouth and RSV
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Hand-foot-and-mouth disease | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory syncytial virus infection | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release